Antiviral azaindole derivatives

Details for Australian Patent Application No. 2001232895 (hide)

Owner Bristol-Myers Squibb Company

Inventors Wallace, Owen B.; Wang, Tao; Bender, John A.; Meanwell, Nicholas A.; Zhang, Zhongxing

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001232895

PCT Pub. Number WO01/62255

Priority 60184004 22.02.00 US

Filing date 19 January 2001

Wipo publication date 3 September 2001

Acceptance publication date 17 March 2005

International Classifications

A61K 031/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

17 March 2005 Application Accepted

  Published as AU-B-2001232895

14 July 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001232897

2001232894